Skip to main content
Rafael Holdings, Inc. logo

Rafael Holdings, Inc. — Investor Relations & Filings

Ticker · RFL ISIN · US75062C1009 US Professional, scientific and technical activities
Filings indexed 393 across all filing types
Latest filing 2025-03-25 Director's Dealing
Country US United States of America
Listing US RFL

About Rafael Holdings, Inc.

https://rafaelholdings.com

Rafael Holdings, Inc. is a clinical-stage biotechnology company that invests in and develops therapies for difficult-to-treat diseases. The company holds interests in early-stage and clinical pharmaceutical entities, with a primary focus on novel cancer therapeutics aimed at improving and extending the lives of patients. Following a merger with Cyclo Therapeutics, Rafael Holdings is also advancing a potential breakthrough treatment for Niemann-Pick Type C1, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2025-03-25 English
4
Director's Dealing
2025-03-25 English
CURRENT REPORT
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 20, 2025, by Rafael Holdings, Inc. It reports the submission of matters to a vote of security holders at a special meeting, specifically the approval of a share issuance related to a merger and the approval of an adjournment for further solicitation of proxies. The content focuses on voting results from a shareholder meeting rather than financial results, management changes, or other report types. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 5421 characters, which is sufficient to include detailed voting results, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2025-03-24 English
FOR REGISTRATION OF CERTAIN CLASSES
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It includes details about the securities to be registered (warrants to purchase shares of Class B common stock) and references other registration statements. The document is a regulatory filing related to securities registration, not a financial report, earnings release, or management information. It is not an announcement of a report but the actual registration form. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2025-03-17 English
QUARTERLY REPORT
Interim / Quarterly Report Q2 2025
2025-03-13 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC by Rafael Holdings, Inc. It reports the results of operations for the fiscal quarter ended January 31, 2025, and includes a press release as Exhibit 99.1. The text explicitly states that the company "distributed over a wire service and posted an earnings release" and that the press release is furnished as an exhibit. The Form 8-K is a current report used to announce material events, including earnings releases, but it is not the earnings release itself. The document is relatively short (5146 characters) and primarily serves to announce and furnish the earnings release rather than provide detailed financial statements or analysis. According to the classification rules, an initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). Since the document includes the earnings release as an exhibit and announces quarterly results, the appropriate classification is Earnings Release (ER).
2025-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.